FIELD: pharmaceutics.
SUBSTANCE: disclosed is a method for preparing solid procarbazine dosage form, in which at temperature of 40-45 °C mannitol, procarbazine hydrochloride and magnesium stearate are mixed, and moistened with starched aqueous solution. Granulates are dried for 10-15 minutes, powdered with mixture of maize starch and talc and encapsulated.
EFFECT: disclosed is method for preparing of procarbazine solid dosage form, having anti-tumour activity.
1 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL GINDARINE MEDICINE AND PRODUCTION METHOD | 2007 |
|
RU2360675C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLID PERORAL MEDICINAL FORM, CONTAINING SYGETHINUM (VERSIONS) | 2007 |
|
RU2338523C1 |
| ANTIVIRAL DRUG AS CAPSULES AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2633085C2 |
| ORAL PHARMACEUTICAL COMPOSITION MEMANTIN (OPTIONS) AND METHOD OF PREPARATION (OPTIONS) | 2007 |
|
RU2326660C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ROSUVASTATIN CALCIUM SALT (VERSIONS) | 2015 |
|
RU2606592C1 |
| SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-DIARRHEA EFFECT | 2004 |
|
RU2276979C2 |
| PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
| PERORAL MEDICINE TILORONE | 2007 |
|
RU2336073C1 |
| MEDICATION POSSESSING ANTIFUNGAL ACTIVITY | 2008 |
|
RU2397765C2 |
